According to a recent study titled ‘APAC Aesthetic Injectable Market Analysis, 2020’, available with Market Study Report, APAC aesthetic injectable market is expected to register an appreciable growth rate over 2020-2025.
 

As per the report findings, rising demand for cosmetic procedures and growing cognizance regarding aesthetic treatments among the populace are driving APAC aesthetic injectable market growth. Moreover, prevalence of affordable facial injectables and booming aging population will significantly expand the industry size in the forthcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2822572/
 

Based on end-user spectrum, APAC aesthetic injectable industry is fragmented into dermatology clinics, hospitals, and others. Among these, dermatology clinics segment secured a sizeable market share in 2019 and will likely witness modest gains over the forecast timeframe. Escalating demand for long-lasting effects of aesthetic treatments, growing establishment of new skin clinics, along with increasing partnership & collaboration of key players with healthcare professionals are fostering the segmental expansion.
 

Besides this, the other segments covered in APAC aesthetic injectable market report are product type, dermal filler material type, applications, and geographies. All the segments are meticulously assessed to the outline the top growth avenues during the forecast period.
 

The product landscape of the market is split into botulinum toxin and dermal filler (biodegradable and non-biodegradable). Moving on, the dermal filler material type segmentation includes collagen, fat injection, hyaluronic acid, polylactic acid, calcium hydroxylapatite, Polymethyl-Methacrylate Microspheres (Pmma), and others.
 

Considering of the application spectrum, the market is categorized into lip augmentation, facial line correction, face lift, lipoatrophy treatment, acne scar treatment, and others. Lastly, the geographical bifurcation of the industry includes China, India, South Korea, Australia, Japan, Malaysia, Thailand, and Rest of APAC.
 

Speaking of the competitive arena, top contenders in APAC aesthetic injectable market sphere are Ipsen Pharma, Teoxane Laboratories, Sinclair Pharma, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Medy Tox, Inc., and Allergan plc.